Abstract：
BACKGROUND:Microarray gene-profiling of invasive breast cancer has identified different subtypes including luminal A, luminal B, HER2-overexpressing and basal-like groups. Basal-like invasive breast cancer is associated with a worse prognosis. However, the prognosis of basal-like ductal carcinoma in situ (DCIS) is still unknown. Our aim was to study the prognosis of basal-like DCIS in a large population-based cohort. METHODS:All 458 women with a primary DCIS diagnosed between 1986 and 2004, in Uppland and Västmanland, Sweden were included. TMA blocks were constructed. To classify the DCIS tumors, we used immunohistochemical (IHC) markers (estrogen-, progesterone-, HER2, cytokeratin 5/6 and epidermal growth factor receptor) as a surrogate for the gene expression profiling. The association with prognosis was examined for basal-like DCIS and other subtypes using Kaplan-Meier survival analyses and Cox proportional hazards regression models. RESULTS:IHC data were complete for 392 women. Thirty-two were basal-like (8.2%), 351 were luminal or HER2-positive (89.5%) and 9 unclassified (2.3%). Seventy-six women had a local recurrence of which 34 were invasive. Another 3 women had general metastases as first event. Basal-like DCIS showed a higher risk of local recurrence and invasive recurrence 1.8 (Confidence interval (CI) 95%, 0.8-4.2) and 1.9 (0.7-5.1), respectively. However, the difference was not statistically significant. Also, no statistically significant increased risk was seen for triple-negative or high grade DCIS. CONCLUSIONS:Basal-like DCIS showed about a doubled, however not statistically significant risk for local recurrence and developing invasive cancer compared with the other molecular subtypes. Molecular subtyping was a better prognostic parameter than histopathological grade.
journal_name
BMC Cancerjournal_title
BMC cancerauthors
Zhou W,Jirström K,Johansson C,Amini RM,Blomqvist C,Agbaje O,Wärnberg Fdoi
10.1186/1471-2407-10-653subject
Has Abstractpub_date
2010-11-30 00:00:00pages
653issn
1471-2407pii
1471-2407-10-653journal_volume
10pub_type
杂志文章相关文献
BMC CANCER文献大全abstract：BACKGROUND:Ovarian carcinoma is a rarely curable disease, for which new treatment options are required. As agents that block HMG-CoA reductase and the mevalonate pathway, the statin family of drugs are used in the treatment of hypercholesterolemia and have been shown to trigger apoptosis in a tumor-specific manner. Rec...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-10-103
更新日期：2010-03-18 00:00:00
abstract：BACKGROUND:Golgi phosphoprotein 3 (GOLPH3) has been identified as an oncoprotein in various human cancers; however, its role in pancreatic ductal adenocarcinoma (PDAC) is unknown. We examined GOLPH3 expression levels and relationship with survival in patients with PDAC to establish the significance of GOLPH3 in the dev...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-571
更新日期：2014-08-07 00:00:00
abstract：BACKGROUND:As inadequate pain communication contributes to difficulties in optimizing outcomes of outpatients, we investigated the effect of reinforced education using WeChat App to the opioid titration treatment of cancer-related pain in the outpatient setting. METHODS:We conducted a prospective study to compare rein...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07270-w
更新日期：2020-09-04 00:00:00
abstract：BACKGROUND:Cytokines are involved in cancer invasion and metastasis. Circulating tumor cells (CTCs) play key role in tumor dissemination and are an independent survival predictor in breast cancer patients. The aim of this study was to assess correlation between CTCs and plasma cytokines in primary breast cancer (PBC) p...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2143-2
更新日期：2016-02-19 00:00:00
abstract：BACKGROUND:Recent large trials have shown the survival benefits of 10-year use of tamoxifen by reducing late recurrence compared with 5-year therapy in estrogen receptor(ER)-positive breast cancer. We tried to identify clinical factors associated with the late recurrence. METHODS:We reviewed our database of ER-positiv...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2423-x
更新日期：2016-07-07 00:00:00
abstract：BACKGROUND:A candidate oncogene GIG47, previously known as a neudesin with a neurotrophic activity, was identified by applying the differential expression analysis method. METHODS:As a first step to understand the molecular role of GIG47, we analyzed the expression profile of GIG47 in multiple human cancers including ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-274
更新日期：2012-07-02 00:00:00
abstract：BACKGROUND:Diabetes is related with increased cancer mortality across multiple cancer types. Its role in lung cancer mortality is still unclear. We aim to determine the prognostic value of fasting plasma glucose (FPG) and diabetes mellitus in patients with locally advanced non-small cell lung cancer (NSCLC) treated wit...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5370-5
更新日期：2019-02-21 00:00:00
abstract：BACKGROUND:Double stranded RNA (dsRNA) has multiple anti-tumor mechanisms. Over the past several decades, there have been numerous attempts to utilize synthetic dsRNA to control tumor growth in animal models and clinical trials. Recently, it became clear that intracellular dsRNA is more effective than extracellular dsR...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-11-110
更新日期：2011-03-28 00:00:00
abstract：BACKGROUND:Everolimus, an inhibitor of mammalian target of rapamycin (mTOR), has been shown to increase the efficacy of endocrine therapies in hormone receptor (HR)-positive metastatic breast cancer. However, because breast cancer is a highly heterogeneous disease, the responses of different patients to everolimus may ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5668-3
更新日期：2019-05-14 00:00:00
abstract：BACKGROUND:Reliable methods are needed to identify patients with early-stage cancer or high-grade precancerous lesions in the pancreas. Analysis of pancreatic juice to detect somatic mutations could represent one such approach. Here we investigated the concordance between mutations found in the primary tumor and pancre...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-5195-7
更新日期：2019-01-05 00:00:00
abstract：BACKGROUND:Triple-negative (TN) breast cancer, which is defined as being negative for the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER-2), represents a subset of breast cancer with different biologic behaviour. We investigated the clinicopathologic charac...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-8-307
更新日期：2008-10-23 00:00:00
abstract：BACKGROUND:Several stromal cell subtypes including macrophages contribute to tumor progression by inducing epithelial-mesenchymal transition (EMT) at the invasive front, a mechanism also linked to metastasis. Tumor associated macrophages (TAM) reside mainly at the invasive front but they also infiltrate tumors and in t...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-35
更新日期：2012-01-24 00:00:00
abstract：BACKGROUND:B7-H4, a co-inhibitory molecule of the B7 family, can restrain T cell proliferation, cytokine secretion and the development of cytotoxicity. B7-H4 is expressed in tumor tissues at a higher level than in normal tissues, and has a potential effect to protect tumors from anti-tumor immune responses. This case-c...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-9-394
更新日期：2009-11-11 00:00:00
abstract：BACKGROUND:In a phase I study of angiotensin-(1-7) [Ang-(1-7)], clinical benefit was associated with reduction in plasma placental growth factor (PlGF) concentrations. The current study examines Ang-(1-7) induced changes in biomarkers according to cancer type and investigates mechanisms of action engaged in vitro. MET...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-404
更新日期：2012-09-11 00:00:00
abstract：BACKGROUND:HER2/neu overexpression is linked to promotion of angiogenesis in breast cancer. We therefore tested the activity of the combination of Trastuzumab with metronomic, low dose chemotherapy with cyclophosphamide (CTX) and methotrexate (MTX) in metastatic breast cancer (MBC). METHODS:Between April 2002 and June...
journal_title：BMC cancer
pub_type： 临床试验,杂志文章
doi：10.1186/1471-2407-6-225
更新日期：2006-09-15 00:00:00
abstract：BACKGROUND:First-line treatment with FOLFOXIRI plus bevacizumab (BEV) is highly effective and regarded as one of the standards-of-care for patients with metastatic colorectal cancer (mCRC), despite the high incidence of neutropenia and diarrhea as side effects. AXEPT, an Asian phase III study, showed that modified CAPI...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07186-5
更新日期：2020-07-23 00:00:00
abstract：BACKGROUND:Little information is available concerning how patient delay may be affected by mass disasters. The main objectives of the present study are to identify whether there was a post-disaster increase in the risk of experiencing patient delay among breast cancer patients in an area affected by the 2011 triple dis...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3412-4
更新日期：2017-06-19 00:00:00
abstract：BACKGROUND:About 85% of breast cancer patients attending Komfo Anokye Teaching Hospital (KATH), Ghana, present with stage III/IV disease. In spite of great investments into the early diagnosis and management of breast cancer, late presentation persists and poses a barrier to realising the possible benefits of the gains...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07520-x
更新日期：2020-10-19 00:00:00
abstract：CORRECTION:After publication of the original article [1] the authors found that the figure contained an incorrect version of Fig. 3a. This does not affect the results and conclusions of the article. ...
journal_title：BMC cancer
pub_type： 杂志文章,已发布勘误
doi：10.1186/s12885-017-3767-6
更新日期：2018-01-11 00:00:00
abstract：BACKGROUND:Spontaneous regression/complete resistance (SR/CR) mice are a unique colony of mice that possess an inheritable, natural cancer resistance mediated primarily by innate cellular immunity. This resistance is effective against sarcoma 180 (S180) at exceptionally high doses and these mice remain healthy. METHOD...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-10-179
更新日期：2010-05-03 00:00:00
abstract：BACKGROUND:The metabolic consequences of preoperative carbohydrate load in breast cancer patients are not known. The present explorative study investigated the systemic and tumor metabolic changes after preoperative per-oral carbohydrate load and their influence on tumor characteristics and survival. METHODS:The study...
journal_title：BMC cancer
pub_type： 杂志文章,随机对照试验
doi：10.1186/s12885-019-6393-7
更新日期：2019-12-04 00:00:00
abstract：BACKGROUND:Lung cancer (LC) is the leading cause of cancer-related deaths. Oxidative DNA damage may contribute to the cancer risk. The antioxidant paraoxonase (PON1) is an endogenous free radical scavenger in the human body. The aim of this study was to determine serum PON1 and arylesterase (ARE) activities in patients...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-7-48
更新日期：2007-03-15 00:00:00
abstract：BACKGROUND:Ovarian cancer is associated with poor long-term survival due to late diagnosis and development of chemoresistance. Tumour hypoxia is associated with many features of tumour aggressiveness including increased cellular proliferation, inhibition of apoptosis, increased invasion and metastasis, and chemoresista...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1539-8
更新日期：2015-07-25 00:00:00
abstract：BACKGROUND:The Src homology phosphotyrosyl phosphatase 2 (SHP2) is a positive effector of cell growth and survival signaling as well transformation induced by multiple tyrosine kinase oncogenes. Since the basal-like and triple-negative breast cancer (BTBC) is characterized by dysregulation of multiple tyrosine kinase o...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1131-2
更新日期：2015-03-08 00:00:00
abstract：BACKGROUND:FMS-like tyrosine kinase 3 (FLT3) is a commonly mutated protein in a variety of human acute leukemias. Mutations leading to constitutively active FLT3, including internal tandem duplications of the juxtamembrane domain (ITD), result in continuous cellular proliferation, resistance to apoptotic cell death, an...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-11-38
更新日期：2011-01-27 00:00:00
abstract：BACKGROUND:Borderline resectable pancreatic cancer (BRPC) is frequently associated with positive surgical margins and a poor prognosis because the tumor is in contact with major vessels. This study evaluated the relationship between the margin-negative (R0) resection rate and findings indicating peripancreatic vascular...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07698-0
更新日期：2020-12-02 00:00:00
abstract：BACKGROUND:Interleukin 12 (IL-12) is a cytokine that has been reported to exhibit potent tumoricidal effects in animal tumor models. A combined approach using Paclitaxel and platinum-based doublet chemotherapy is the most commonly used backbone regimen for treating lung cancer. Despite numerous studies regarding the an...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2701-7
更新日期：2016-08-22 00:00:00
abstract：BACKGROUND:Pelvic inflammatory disease (PID) is characterized by infection and inflammation of the upper genital tract in women and is associated with health sequelae. We used a nationwide population-based retrospective cohort study to explore the relationship between PID and the subsequent development of gynecological...
journal_title：BMC cancer
pub_type： 杂志文章,随机对照试验
doi：10.1186/s12885-016-2857-1
更新日期：2016-11-03 00:00:00
abstract：BACKGROUND:Tobacco smoking is associated with a unique mutational signature in the human cancer genome. It is unclear whether tobacco smoking-altered DNA methylations and gene expressions affect smoking-related mutational signature. METHODS:We systematically analyzed the smoking-related DNA methylation sites reported ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-07368-1
更新日期：2020-09-14 00:00:00
abstract：BACKGROUND:Lymphocyte Function-Associated Antigen-1 (LFA-1; CD18/CD11a) is one of the main adhesion molecules used by immune cells to infiltrate the liver under inflammatory conditions. Recently, the expression of this integrin has also been reported on several solid tumors, including colorectal cancer. However, its fu...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3823-2
更新日期：2017-12-06 00:00:00
